Acasti Pharma Inc.
ACST
Clasificación en acciones
#29736
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Precio por acción
$0.4256834
Última sincronización: 2023-03-27
Capitalización bursátil
$18.99M
Cambio (1 día)
3.08%
Cambio (1 año)
-87.02%
País
CA
Comercio Acasti Pharma Inc. (ACST)
Categoría
Healthcare
Ratio P/S de Acasti Pharma Inc. (ACST)
Ratio P/S al October 2026 TTM: 0.00
Según los informes financieros más recientes y el precio de las acciones de Acasti Pharma Inc., el ratio P/S actual (TTM) es 0.00. Al final de 2024, el ratio P/S era 0.00.
Historial del ratio P/S de Acasti Pharma Inc. desde 2010 hasta 2026
Ratio P/S al final de cada año
| Año | Ratio P/S | Cambiar |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | -100.00% |
| 2021 | 37.95 | 0.00% |
| 2020 | 0.00 | 0.00% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | -100.00% |
| 2016 | 32.56 | 746.49% |
| 2015 | 3.85 | 195.83% |
| 2014 | 1.30 | 95.64% |
| 2013 | 0.66 | -98.33% |
| 2012 | 39.84 | 270.24% |
| 2011 | 10.76 | 0.00% |
| 2010 | 0.00 | 0.00% |
Ratio P/S de empresas similares o competidoras
| Empresa | Ratio P/S | Diferencia del ratio P/S | País |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 3.96 | - |
AU
|
|
| - | - |
CH
|
|
| 10.15 | - |
NL
|
